In today’s recent session, 0.45 million shares of the Compass Pathways Plc ADR (NASDAQ:CMPS) have been traded, and its beta is 2.27. Most recently the company’s share price was $3.53, and it changed around $0.04 or 1.15% from the last close, which brings the market valuation of the company to $241.52M. CMPS at last check was trading at a discount to its 52-week high of $12.75, offering almost -261.19% off that amount. The share price’s 52-week low was $3.16, which indicates that the recent value has risen by an impressive 10.48% since then. We note from Compass Pathways Plc ADR’s average daily trading volume that its 10-day average is 1.55 million shares, with the 3-month average coming to 1.09 million.
Compass Pathways Plc ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended CMPS as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Compass Pathways Plc ADR is expected to report earnings per share of -0.62 for the current quarter.
Compass Pathways Plc ADR (NASDAQ:CMPS) trade information
Instantly CMPS has been showing a green trend so far today with a performance of 1.15% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.78 on recent trading dayincreased the stock’s daily price by 6.61%. The company’s shares are currently down -6.61% year-to-date, but still up 4.75% over the last five days. On the other hand, Compass Pathways Plc ADR (NASDAQ:CMPS) is -15.95% down in the 30-day period. We can see from the shorts that 3.89 million shares have been sold at a short interest cover period of 5.49 day(s).
The consensus price target as assigned by Wall Street analysts is $23, which translates to bulls needing to increase their stock price by 84.65% from its current value. Analyst projections state that CMPS is forecast to be at a low of $23 and a high of $23.
Compass Pathways Plc ADR (CMPS) estimates and forecasts
Compass Pathways Plc ADR share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -51.64 percent over the past six months and at a -0.43% annual growth rate that is well below the industry average of 6.60%.
Forecasts for the next quarter put sales growth at 0.00%.
CMPS Dividends
Compass Pathways Plc ADR’s next quarterly earnings report is expected to be released in February.
Compass Pathways Plc ADR (NASDAQ:CMPS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 16.40% of Compass Pathways Plc ADR shares, and 35.87% of them are in the hands of institutional investors. The stock currently has a share float of 42.90%. Compass Pathways Plc ADR stock is held by 149.0 institutions, with TCG CROSSOVER MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 6.0073% of the shares, which is about 3.86 million shares worth $23.3 million.
CITADEL ADVISORS LLC, with 5.7118% or 3.67 million shares worth $22.16 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ARK ETF Tr-ARK Genomic Revolution ETF and iShares Biotechnology ETF were the top two Mutual Funds as of Nov 30, 2024 . The former held 1.87 shares worth $6.66 million, making up 2.73% of all outstanding shares. On the other hand, iShares Biotechnology ETF held roughly 371.72 shares worth around $1.33 million, which represents about 0.54% of the total shares outstanding.
